Sales rise 73.45% to Rs 8.10 crore
Net Loss of Bharat Immunological & Biological Corporation reported to Rs 5.66 crore in the quarter ended September 2019 as against net loss of Rs 2.51 crore during the previous quarter ended September 2018. Sales rose 73.45% to Rs 8.10 crore in the quarter ended September 2019 as against Rs 4.67 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales8.104.67 73 OPM %-82.47-77.30 -PBDT-7.76-3.60 -116 PBT-7.82-3.70 -111 NP-5.66-2.51 -125Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
